Acquired
Novo Nordisk (Ozempic)
David Rosenthal
But if Kagra Sema, their new kind of next generation GLP-1 product shows the promise that they think it'll have, then that'll be a new patent cycle starting then. And then they'll develop the next generation and it'll play out again, just like insulin. But yes, absolutely cornered resource for sure.
0
💬
0
Comments
Log in to comment.
There are no comments yet.